| 39452 |
A |
IV |
2024/03/25
|
XIAMEN SINOPEG BIOTECH CO LTD |
(2-(2-HYDROXYETHOXY)ETHYL)AZANEDIYL)BIS(HEXANE-6,1-DIYL) BIS(2-HEXYLDECANOATE)(DHA-1) |
| 37785 |
A |
II |
2024/03/25
|
NATCO PHARMA LTD |
LURBINECTEDIN |
| 39540 |
A |
II |
2024/03/25
|
APITORIA PHARMA PRIVATE LTD |
CEFDINIR USP (ANHYDROUS) |
| 39603 |
A |
II |
2024/03/25
|
ZHEJIANG JINGSHENG PHARMACEUTICAL CO LTD |
EMPAGLIFLOZIN |
| 39740 |
A |
II |
2024/03/24
|
ZHEJIANG GUOBANG PHARMACEUTICAL CO LTD |
BREXPIPRAZOLE |
| 39758 |
A |
II |
2024/03/24
|
SICHUAN ELIXIR PHARMACEUTICAL CO LTD |
METHOTREXATE |
| 39663 |
A |
III |
2024/03/22
|
ZHONGSHAN XIAOLAN BAILIBAO ALUMINUM FOIL PACKAGING FACTORY (GENERAL PARTNERSHIP) |
SEAL LINER |
| 39711 |
A |
II |
2024/03/22
|
GLOBAL CALCIUM PRIVATE LTD |
HYDROQUINONE USP |
| 39722 |
A |
II |
2024/03/22
|
SHANGHAI TOFFLON BIO-REAGENT CO LTD |
MSCS SERUM-FREE CULTURE MEDIUM |
| 39757 |
A |
II |
2024/03/22
|
SICHUAN ELIXIR PHARMACEUTICAL CO LTD |
CABOZANTINIB SULFATE |
| 37684 |
A |
II |
2024/03/22
|
BIOCON LTD |
SITAGLIPTIN HYDROCHLORIDE (ENZYMATIC) |
| 39276 |
A |
III |
2024/03/22
|
ZHEJIANG GONDONG MEDICAL TECHNOLOGY CO LTD |
ORAL DRUG FEEDING SYRINGE |
| 39644 |
A |
II |
2024/03/21
|
NATCO PHARMA LTD |
CAPMATINIB HYDROCHLORIDE |
| 39709 |
A |
II |
2024/03/21
|
HENAN LIHUA PHARMACEUTICAL CO LTD |
BETAMETHASONE |
| 39730 |
A |
II |
2024/03/21
|
ZHEJIANG BOXIAO BIOPHARMACEUTICAL CO LTD |
PHENYLEPHRINE HYDROCHLORIDE |
| 39737 |
A |
II |
2024/03/21
|
ZHEJIANG GUOBANG PHARMACEUTICAL CO LTD |
VONOPRAZAN FUMARATE |
| 39538 |
A |
II |
2024/03/21
|
AMI LIFESCIENCES PVT LTD |
VIBEGRON
|
| 39573 |
A |
II |
2024/03/21
|
BIOCON LTD |
TACROLIMUS USP (PROCESS II)
|
| 39574 |
A |
II |
2024/03/21
|
BIOCON LTD |
LURASIDONE HYDROCHLORIDE |
| 39615 |
A |
II |
2024/03/21
|
JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD |
ADENOSINE TRIPHOSPHATE (ATP) TRIS SOLUTION |
请输入需要查询的关联主题/药物名称（英文），DMF持有人（英文），DMF号码